Glenmark Generics Inc. (GGI), USA is the North American division of Glenmark Generics Ltd. (GGL) dedicated to the manufacture, marketing and distribution of generic pharmaceutical products. Read more.

Glenmark Generics (Europe) Limited (GGEL) is the European subsidiary of Glenmark Generics Ltd., engaged in marketing, licensing and distribution of generic products throughout Europe.The generic formulations and API business in Europe has a robust product portfolio developed by a Europe-dedicated R&D team and has excellent supply chain resources. Read more.

Glenmark Generics Argentina is the hub for generic research, manufacturing and distribution of oncology products for the whole world. The company’s continuous growth since then now spans 23 countries. Read More.

Glenmark API is the Active Pharmaceutical Ingredient manufacturing arm of Glenmark Generics. With a presence in over 80 countries Glenmark's API business is among the top 10 in the Indian Generic Pharmaceutical Market. Read more.

May 16, 2012: Glenmark Generics receives tentative approval for zolmitriptan orally disintegrating tablets from the U.S. FDA Read More

May 7, 2012: Glenmark Generics receives U.S. FDA approval for Lamotrigine Tablets Read More